Resources
- Lumisight (pegulicianine) Gains FDA Approval to Detect Residual Cancer
- Advances in Macrocyclic Peptide Drug Development
- Upcoming GLP-1 RAs for NASH: A Comprehensive List
- Targeted Therapies for Systemic Lupus Erythematosus (SLE)
- Small Nucleic Acid Drugs Expected to Be Approved by 2025
- Diabetes & Weight Loss Drug Tirzepatide Now Approved for OSA (Obstructive Sleep Apnea)
- Antibody–Drug Conjugate Payloads: MMAE & MMAF
- Semaglutide vs. Tirzepatide for Obesity
- Beyond HER3-DXd: New Frontiers in HER3-Targeted Therapies for Lung Cancer
- 2024 FDA Approvals: 50 New Drugs
